Cannabis Law Report

DECEMBER 2, 2021

–(BUSINESS WIRE)– #Alzheimers –(NYSE American: IGC), India Globalization Capital, Inc. The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021. POTOMAC, Md.–(BUSINESS

Clinical Trials 52

Clinical Trials Data Patients THC 52

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. About RYAH Group, Inc. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

MAY 16, 2022

Data on injured workers from the nation’s most mature adult-use cannabis market is pretty boring. An analysis of workers’ comp claims from Pinnacol Assurance, Colorado’s largest workers’ compensation insurer, found few things that stood out in claims data from the state’s cannabis industry compared with other industries in the state.

Data 52

Data Strains Safety Cultivation 52

Cannabis Law Report

NOVEMBER 26, 2019

The FDA also published a revised Consumer Update detailing safety concerns about CBD products more broadly. This includes ongoing work to obtain and evaluate information to address outstanding questions related to the safety of CBD products, while maintaining the agency’s rigorous public health standards. Sunflora Inc. ,

Safety 64

Safety Food CBD Oil 64

Cannabis Law Report

AUGUST 27, 2021

The Rules establish the recreational cannabis industry in New Jersey and allow the CRC to begin licensing businesses as soon as possible. New applicants may apply for either a conditional license or an annual license. People with prior criminal convictions can qualify for a cannabis business license.

Cultivation 105

Cultivation Conditions Business Cannabis 105

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike. Understanding these trends is vital for businesses to effectively meet consumer needs and stay competitive in the market.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Cannabis Law Report

AUGUST 27, 2021

The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future. Delic is focused on bringing psychedelic wellness to the mainstream.

Research and Development 98

Research and Development Treatment Media Medicine 98

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Image by Pfüderi from Pixabay.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

JUNE 7, 2021

–(BUSINESS WIRE)– #AD –India Globalization Capital, Inc. (“IGC”) The Data and Safety Monitoring Committee (“DSMC”) for IGC’s clinical trial, having reviewed the data obtained through Cohort 1 and Cohort 2, recommended progressing to Cohort 3, which consists of administering three doses per day.

Clinical Trials 105

Clinical Trials Patients THC Safety 105

Canna Law Blog

JANUARY 17, 2023

Change in business structure. The OLCC’s new rule changes impact how marijuana businesses may be bought and sold. Licensees must submit a notification form to the Commission prior to making any business structure change. A licensee automatically receives conditional approval after five days if a determination is still pending.

Retail 72

Retail Cannabis Conditions Business 72

Cannabis Law Report

AUGUST 4, 2021

The Core Business delivered strong organic growth 13 in H1 2021 (17% year-on-year) despite some of Eurofins’ businesses remaining affected by lockdowns during H1 2021. We thus provide comparison with the pre-pandemic period of H1 2019 as an additional data point. for the three historic TIC leaders.

Business 105

Business Research and Development Environment Food 105

Cannabis Law Report

JUNE 16, 2021

Genetic Screening Platform Technology and Data to Strengthen Entheon’s Psychedelic-Assisted Protocols. Lobo brings a highly experienced and specialized team of technology experts in the fields of genetics, diagnostics, data and analytics, as well as a fully operational 5,000 sq. Vancouver, British Columbia–(Newsfile Corp.

Research and Development 105

Research and Development Data Conditions Events 105

Canna Law Blog

DECEMBER 16, 2021

Psilocybin research license, which will allow the testing potency, conducting clinical investigations, researching efficacy and safety, and agricultural research. Expansive List of Qualifying Medical Conditions. Data from the RAND Corporation show that 8,000 New York veterans from the Wars in Iraq and Afghanistan suffer from PTSD.

Legislation 97

Legislation Treatment Therapy Conditions 97

MMJ Recs

FEBRUARY 23, 2024

This article delves into the multifaceted economic impact of the burgeoning medical marijuana industry in Michigan, exploring various facets such as business growth, financial contributions, employment opportunities, market trends, and the broader implications for local economies.

Marijuana 52

Marijuana Dispensary Research and Development Supply Chain 52

Cannabis Law Report

JUNE 1, 2021

Achieves 37% revenue growth in FY 2021 with strong double-digit growth across both cannabis and other consumer products businesses. “We are starting to see strong momentum across all of our key businesses and remain firmly focused on capitalizing on U.S. Canopy Growth Reports Fourth Quarter and Fiscal Year 2021 Financial Results.

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

AUGUST 17, 2021

–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. We believe the totality of the data is encouraging and supports advancing to Phase 3. Data Highlights. The condition is caused by inherited mutations in either the TSC1 gene or the TSC2 gene. RADNOR, Pa.–(BUSINESS

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Cannabis Law Report

SEPTEMBER 20, 2021

TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp. The products leverage pharmaceutical technology to maximize performance and safety. provides Heritage and subsidiary Opticann the benefits of offering patients access to safe, convenient, and effective CB4 products developed on trusted technology platforms.

Clinical Trials 52

Clinical Trials Pharmaceutical Data Patients 52

Cannabis Law Report

JUNE 19, 2022

Beckley Psytech will use Ksana Health’s Effortless Assessment Research System (EARS), an end-to-end solution for mobile sensing, to collect passive mobile device meta data from clinical trial participant’s smartphones, in order to identify individual signals of potential response and relapse. June 14, 2022 02:00 AM Eastern Daylight Time.

Clinical Trials 52

Clinical Trials Patients Research and Development Treatment 52

WeedAdvisor

SEPTEMBER 5, 2019

Now, Marijuana Business Daily reports yet another contender ready to jump in on this budding industry. Atlas Biotechnologies – a Canadian licensed producer based in Edmonton, Alberta – is about to take its business to Denmark and become a major contributor to production of medical marijuana. A Superior Strategy. .

Compliance 56

Compliance Compliance Conditions Business 56

Cannabis Law Report

JULY 29, 2021

Our evidence-based scientific approach has enabled us to develop a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

Cannabis Law Report

OCTOBER 6, 2021

Flora Pharma will seek to identify scientific gaps in the cannabis industry and ultimately work to translate that to pharmaceutical cannabis products backed by data. MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp. About Flora Growth Corp.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Events 52

Veriheal

OCTOBER 29, 2020

The data for this graphic was provided by Jim Hudson at Hellth.com. . The data provided by Mr. Hudson allows citizens to see how the main share of funding is allocated to seek the negative consequences of cannabis. However, this would see the end, or downsizing, of many businesses that profit off of non-renewable sources.

Pharmaceutical 98

Pharmaceutical Therapy Cannabinoids Chronic Pain 98

Puff Puff Post

MARCH 10, 2020

” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

The Cannigma

AUGUST 24, 2021

Tetragram users log their sessions by data points like strain , product, intake method, how it helped their symptoms, how it looked and tasted, and where they bought it. As co-founder Otha Smith said, “through data, we aim to empower not only cannabis consumers, but the entire industry.”. Oh, and users can always upload photos as well.

Seed-To-Sale 111

Seed-To-Sale Research and Development Data Strains 111

Cannabis Law Report

JULY 23, 2021

The bill includes several provisions for additional research to investigate the impact of legalization on public health, driving safety, and similar areas. of Health and Human Services to research the effects of cannabis on health conditions. Many direct and indirect cannabis business have difficulty accessing loans or other financing.

Research and Development 105

Research and Development DEA Programs State Laws 105

Veriheal

AUGUST 3, 2021

Mainly, the measure protects patient safety and amplifies product quality requirements, all the while entrusting the state’s Medical Marijuana Advisory Board to consider broadening the program’s list of qualifying medical conditions. Pennsylvania’s Medical Cannabis Program is Raking in the Cash.

Legislation 98

Legislation Patients Supply Chain Dispensary 98

Cannabis Law Report

MAY 6, 2022

The FDA explains it is monitoring the selling of CBD and Delta-8 THC products out of a growing safety concern. In short, the FDA has not evaluated or logged all dangerous side effects or safety concerns. Pre-clinical data support the possible use of CBD with Panic Disorder…Bipolar Disorder.”. Taking CBD can relieve pain.”. “In

THC 52

THC CBD Media Food 52

Veriheal

FEBRUARY 3, 2021

The cannabis industry has been busy over the last couple of years, which only makes sense considering the fact that it is becoming increasingly decriminalized and legalized all over the world. This research is great news for conditions such as Alzheimer’s Disease which has a significant and negative impact on memory.

Consumption 52

Consumption Safety THC Cannabis 52

Cannabis Law Report

JUNE 26, 2019

Patients with a specified medical condition should see their medical consultant for advice. Authorisation will be on a named-patient arrangement and subject to the following conditions: Treatment is consultant-initiated. Online reimbursement approval is required for each patient.

Medicine 55

Medicine Access Business Legislation 55

Greenspoon Marder Cannabis Law Group Blog

AUGUST 21, 2019

Although public interest is growing, there is missing data that the FDA needs to consider in order to protect and promote the public health. As a response to one of her initial direct questions, Welch highlighted the stark contrast between CBD in Epidiolex for children with severe seizure conditions and CBD in everyday foods and products.

Hemp 53

Hemp CBD Food Collective 53

WeedAdvisor

SEPTEMBER 26, 2019

As Illinois prepares to follow through with their recreational marijuana rollout, Marijuana Business Daily reports the state’s biggest increase in medical cannabis sales throughout the program’s history. He also expanded the list of qualifying conditions, opening the door for a broader group of patients.

Recreational 45

Recreational Patients Programs History 45

Cannabis Law Report

FEBRUARY 17, 2022

Mycotoxins are contaminants that licensees are required to screen for to uphold public health, safety, and welfare. The Commission continues to actively monitor the licensee’s compliance with the conditions of the Order including the licensee’s Standard Operating Procedures relative to product recalls and notification to the public.

Marijuana 52

Marijuana Seed-To-Sale Safety Patients 52

The Joint Blog

JUNE 8, 2020

“Niagara College will prepare you with the skills to begin working in the cannabis business.” Interpret data to assess crop health and quality and adapt to growth conditions/pest management strategies. Niagara College will prepare you with the skills to begin working in the cannabis business.

Programs 32

Programs Research and Development Environment Packaging 32

Cannabis Law Report

DECEMBER 16, 2021

CDC Issues “Best Practices” for Businesses on Employed Drivers and Cannabis Use. Because recreational use of marijuana is increasing, especially as more states legalize it, the CDC believes it’s important for all workplaces to implement and address marijuana policies in their motor vehicle safety programs. Newsworthy Highlights.

Cannabinoids 52

Cannabinoids Retail Policy Cultivation 52

Cannabis Law Report

JUNE 7, 2021

& ROME–(BUSINESS WIRE)– $APDN #COVIDDiagnostics — Applied DNA Sciences, Inc. 1.526 were reduced as expected and consistent with other CDC-reported data on vaccine-induced antibody neutralization against these variants 1. STONY BROOK, N.Y. & P1 (Brazil), and B.1.526 1.526 (New York) SARS-CoV-2 variants.

Clinical Trials 64

Clinical Trials Research and Development Therapy Supply Chain 64

Cannabis Law Report

NOVEMBER 16, 2021

Phase 2 trial recruiting begins immediately; efficacy data expected by the end of the first quarter of 2022. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Recruitment for the Phase 2 trial will begin immediately, and efficacy data is expected by the end of first quarter of 2022. “To

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

APRIL 14, 2022

Cannabis businesses that are ill-prepared for these regulatory requirements risk facing litigation, enforcement actions, fines or penalties, and negative publicity, while those taking a proactive approach to compliance may find opportunities to mitigate and even monetize those risks. Waste Management Issues. Energy Use.

Environment 52

Environment Agriculture Compliance Compliance 52